143 related articles for article (PubMed ID: 7667607)
1. Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL).
Bjøro T; Mørkrid L; Wergeland R; Turter A; Kvistborg A; Sand T; Torjesen P
Scand J Clin Lab Invest; 1995 Apr; 55(2):139-47. PubMed ID: 7667607
[TBL] [Abstract][Full Text] [Related]
2. Different responses in little and bigbig prolactin to metoclopramide in subjects with hyperprolactinemia due to 150-170 kD (bigbig) prolactin.
Bjøro T; Johansen E; Frey HH; Turter A; Torjesen PA
Acta Endocrinol (Copenh); 1993 Apr; 128(4):308-12. PubMed ID: 8498149
[TBL] [Abstract][Full Text] [Related]
3. Characterization of big, big prolactin in patients with hyperprolactinaemia.
Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
[TBL] [Abstract][Full Text] [Related]
4. On the nature of serum prolactin in two patients with macroprolactinemia.
Carlson HE; Markoff E; Lee DW
Fertil Steril; 1992 Jul; 58(1):78-87. PubMed ID: 1624027
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
[TBL] [Abstract][Full Text] [Related]
6. The detection of macroprolactin by precipitation and ultrafiltration methods.
Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
[TBL] [Abstract][Full Text] [Related]
7. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
8. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
Olukoga AO; Kane JW
Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
[TBL] [Abstract][Full Text] [Related]
9. The natural history of macroprolactinaemia.
Hattori N; Adachi T; Ishihara T; Shimatsu A
Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016
[TBL] [Abstract][Full Text] [Related]
10. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
[TBL] [Abstract][Full Text] [Related]
11. Macroprolactinaemia associated with prolactin adenoma.
Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
[TBL] [Abstract][Full Text] [Related]
13. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
14. [Macroprolactin in subjects with hyperprolactinaemia: clinical observations and relations between free PRL and PRL complexed with IgG].
Jeske W; Zgliczyński W; Gorzelak K
Endokrynol Pol; 2005; 56(5):779-84. PubMed ID: 16817144
[TBL] [Abstract][Full Text] [Related]
15. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.
Smith TP; Suliman AM; Fahie-Wilson MN; McKenna TJ
J Clin Endocrinol Metab; 2002 Dec; 87(12):5410-5. PubMed ID: 12466327
[TBL] [Abstract][Full Text] [Related]
16. Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states.
Smith CR; Butler J; Hashim I; Norman MR
Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():3-8. PubMed ID: 2310154
[TBL] [Abstract][Full Text] [Related]
17. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients.
Ciccarelli E; Grottoli S; Razzore P; Gianotti L; Arvat E; Deghenghi R; Camanni G; Ghigo E
Clin Endocrinol (Oxf); 1996 Jan; 44(1):67-71. PubMed ID: 8706295
[TBL] [Abstract][Full Text] [Related]
18. Clinical and radiological features of patients with macroprolactinaemia.
Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
[TBL] [Abstract][Full Text] [Related]
19. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
[TBL] [Abstract][Full Text] [Related]
20. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
